Developer docs
API playgroundTry for free, no card

Search company profiles

NYtor

Full company profile

uuid0036say

Namestring
NYtor
Websiteurl
nytor.nl
Company typeenum
Private
Founded yearint
2007
Descriptiontext

NYtor is a privately held biotechnology research company headquartered in Nijmegen, Netherlands, founded in 2007. The company provides quantitative PCR (qPCR) services, molecular beacon probe-based assays, and antibiotic resistance research, positioning it as a specialty molecular biology and microbiology research services provider.

The firm's product surface is narrow and technical, centered on three service lines: nucleic acid amplification quantification via qPCR, custom molecular beacon probe design and application, and laboratory analysis related to antibiotic resistance phenotypes or genotypes. These offerings suggest a contract-research or technical-services business model serving academic researchers, clinical laboratories, or pharmaceutical/biotech R&D groups in need of molecular assay development and antimicrobial resistance work.

With a documented headcount of 1-10 employees, NYtor operates as a micro-scale specialist. Its revenue mechanics, customer segments, pricing structure, funding history, and management team are not disclosed in the available source material — the second-stage web page returned a loading/verification page with no substantive corporate information. As a result, the company's commercial scale, geographic reach beyond the Netherlands, and go-to-market motion cannot be characterized from available evidence, and the operational footprint should be assumed to be limited absent contradictory signals.

Short descriptiontext

NYtor is a Nijmegen, Netherlands-based biotechnology research company, founded in 2007 with 1-10 employees, that provides quantitative PCR services, molecular beacon technology, and antibiotic resistance research to scientific and laboratory clients in the molecular biology and microbiology space.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNijmegen, Netherlands
HQ citystring
Nijmegen
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
quantitative PCR services, molecular beacon probes, antibiotic resistance testing, molecular diagnostics, biotechnology research
Industry1 code
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
  • Testing Laboratories and Services541380
SIC code4 codes
  • Services-Commercial Physical & Biological Research8731
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
  • Laboratory Analytical Instruments3826
Product category
Biotechnology Research Services
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NYtor is a biotechnology research company that performs quantitative PCR (qPCR) analyses, designs and supplies molecular beacon–based detection assays, and delivers antibiotic resistance testing/characterization services. These services are aimed at laboratories and researchers requiring molecular-level nucleic acid detection and antimicrobial resistance profiling.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Quantitative PCR Services
CategoryMolecular Diagnostics Services
No data
Peers10 records
TypeBroad incumbent
Description

Major provider of qPCR kits, molecular diagnostics, and sample preparation technologies for clinical and research labs; competes in the same PCR/qPCR workflow space NYtor serves.

TypeBroad incumbent
Description

Offers Applied Biosystems qPCR instruments and reagents plus a broad molecular biology portfolio; overlaps with NYtor in serving qPCR-using researchers and diagnostics labs.

TypeBroad incumbent
Description

Operates the GeneXpert molecular diagnostics platform with menu including MRSA and antimicrobial resistance tests; relevant comparable for the clinical AMR molecular diagnostics market NYtor targets.

4TATAA Biocenter
TypeDirect peer
Description

European contract research organization offering qPCR services, training, and assay development; direct competitor for specialized qPCR and molecular beacon-based service contracts.

TypeDirect peer
Description

Belgian manufacturer of qPCR reagents, probes, and oligonucleotides with strong European presence; comparable in offering custom molecular biology reagents used in qPCR workflows.

TypeDirect peer
Description

Designs and manufactures custom qPCR probes, primers, and assay reagents used in molecular biology research; mirrors NYtor's bead-based/qPCR chemistry expertise at larger scale.

TypeBroad incumbent
Description

Global leader in qPCR instruments, reagents, and digital PCR (ddPCR), directly serving the same molecular biology customer base that NYtor supports. Larger scale and broader menu, but comparable in core technology.

TypeDirect peer
Description

Specializes in custom oligonucleotide probes including molecular beacon and qPCR probe design, directly comparable to NYtor's molecular beacon capability and qPCR reagent offerings.

TypeEmerging player
Description

Developed molecular diagnostic tests for infectious disease and antimicrobial resistance, illustrating the trajectory where qPCR expertise can scale into clinical IVD products.

TypeBroad incumbent
Description

Global contract testing organization with antimicrobial resistance and molecular testing services; competes with NYtor for outsourced microbiology and resistance-gene testing contracts.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NYtor

Biotechnology Research Servicesnytor.nl

NYtor is a Nijmegen, Netherlands-based biotechnology research company, founded in 2007 with 1-10 employees, that provides quantitative PCR services, molecular beacon technology, and antibiotic resistance research to scientific and laboratory clients in the molecular biology and microbiology space.

What NYtor does

NYtor is a privately held biotechnology research company headquartered in Nijmegen, Netherlands, founded in 2007. The company provides quantitative PCR (qPCR) services, molecular beacon probe-based assays, and antibiotic resistance research, positioning it as a specialty molecular biology and microbiology research services provider.

The firm's product surface is narrow and technical, centered on three service lines: nucleic acid amplification quantification via qPCR, custom molecular beacon probe design and application, and laboratory analysis related to antibiotic resistance phenotypes or genotypes. These offerings suggest a contract-research or technical-services business model serving academic researchers, clinical laboratories, or pharmaceutical/biotech R&D groups in need of molecular assay development and antimicrobial resistance work.

With a documented headcount of 1-10 employees, NYtor operates as a micro-scale specialist. Its revenue mechanics, customer segments, pricing structure, funding history, and management team are not disclosed in the available source material — the second-stage web page returned a loading/verification page with no substantive corporate information. As a result, the company's commercial scale, geographic reach beyond the Netherlands, and go-to-market motion cannot be characterized from available evidence, and the operational footprint should be assumed to be limited absent contradictory signals.

NYtor firmographics

Firmographics
Name
NYtor
Website
https://nytor.nl
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
NYtor is a Nijmegen, Netherlands-based biotechnology research company, founded in 2007 with 1-10 employees, that provides quantitative PCR services, molecular beacon technology, and antibiotic resistance research to scientific and laboratory clients in the molecular biology and microbiology space.
Ownership category
akta.pro rank

NYtor industry classification

Industry
Product category
Biotechnology Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (541380)
SIC
Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • Quantitative PCR services
  • Molecular beacon probes
  • Antibiotic resistance testing
  • Molecular diagnostics
  • Biotechnology research

Where NYtor is headquartered

Location

Headquarters

HQ city
Nijmegen
HQ country
Netherlands
HQ region
Europe

Markets served

NYtor business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

NYtor product offering

Product offering

Core offering

NYtor is a biotechnology research company that performs quantitative PCR (qPCR) analyses, designs and supplies molecular beacon–based detection assays, and delivers antibiotic resistance testing/characterization services. These services are aimed at laboratories and researchers requiring molecular-level nucleic acid detection and antimicrobial resistance profiling.

Differentiator

Problem solved

Functional benefit

Products and services

  • Quantitative PCR Services

Companies that use NYtor

Customer profile

Ideal customer profiles1 record

NYtor technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

NYtor competitors and assessment

Company assessment

Broad incumbents

  • QIAGEN: Major provider of qPCR kits, molecular diagnostics, and sample preparation technologies for clinical and research labs; competes in the same PCR/qPCR workflow space NYtor serves.
  • Thermo Fisher Scientific (Life Sciences): Offers Applied Biosystems qPCR instruments and reagents plus a broad molecular biology portfolio; overlaps with NYtor in serving qPCR-using researchers and diagnostics labs.
  • Cepheid (Danaher): Operates the GeneXpert molecular diagnostics platform with menu including MRSA and antimicrobial resistance tests; relevant comparable for the clinical AMR molecular diagnostics market NYtor targets.
  • Bio-Rad Laboratories: Global leader in qPCR instruments, reagents, and digital PCR (ddPCR), directly serving the same molecular biology customer base that NYtor supports. Larger scale and broader menu, but comparable in core technology.
  • Eurofins Scientific: Global contract testing organization with antimicrobial resistance and molecular testing services; competes with NYtor for outsourced microbiology and resistance-gene testing contracts.

Direct peers

  • TATAA Biocenter: European contract research organization offering qPCR services, training, and assay development; direct competitor for specialized qPCR and molecular beacon-based service contracts.
  • Eurogentec: Belgian manufacturer of qPCR reagents, probes, and oligonucleotides with strong European presence; comparable in offering custom molecular biology reagents used in qPCR workflows.
  • Integrated DNA Technologies (IDT): Designs and manufactures custom qPCR probes, primers, and assay reagents used in molecular biology research; mirrors NYtor's bead-based/qPCR chemistry expertise at larger scale.
  • LGC Biosearch Technologies: Specializes in custom oligonucleotide probes including molecular beacon and qPCR probe design, directly comparable to NYtor's molecular beacon capability and qPCR reagent offerings.

Emerging players

  • Mobidiag (now part of Hologic): Developed molecular diagnostic tests for infectious disease and antimicrobial resistance, illustrating the trajectory where qPCR expertise can scale into clinical IVD products.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

NYtor social profiles

Digital presence

NYtor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NYtor leadership team

Management profile

Number of profiles

NYtor funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NYtor M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NYtor

What does NYtor do?

NYtor is a biotechnology research company that performs quantitative PCR (qPCR) analyses, designs and supplies molecular beacon–based detection assays, and delivers antibiotic resistance testing/characterization services. These services are aimed at laboratories and researchers requiring molecular-level nucleic acid detection and antimicrobial resistance profiling.

When was NYtor founded?

NYtor was founded in 2007. It employs 1 to 10 people.

Where is NYtor based?

NYtor is headquartered in Nijmegen, Netherlands, in the Europe region.

Who are NYtor's main competitors?

Broad incumbents on record are QIAGEN, Thermo Fisher Scientific (Life Sciences), Cepheid (Danaher), Bio-Rad Laboratories and Eurofins Scientific. Direct peers are TATAA Biocenter, Eurogentec, Integrated DNA Technologies (IDT) and LGC Biosearch Technologies. Mobidiag (now part of Hologic) is listed as an emerging player.

Does NYtor have an API?

No public API is recorded for NYtor.

What industry is NYtor in?

NYtor's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales